Cipla to support Terra Carta, for sustainable future

Since its launch in January 2021, the initiative has received support from 223 private sector organisations and 21 professional associations. Cipla is one of the five Indian companies and the only Indian pharmaceutical company to participate.

While continuing to achieve its own environmental, social and governance (ESG) goals, Cipla would also have the opportunity to drive ESG discourse within the sector and at a regional level. At the same time, the initative would allow participating organizations to cross-learn from one another.

Mr Umang Vohra, MD & Global CEO, Cipla said "Achieving sustainable and equitable growth is one of the greatest challenges and the need of this century. The pandemic has shown what can be achieved with the power of the collective, and the healthcare and the pharma sector has been at the forefront of it. I commend HRH Prince of Wales for leading Terra Carta and bringing together business leaders on Agenda 2030. We are committed to contributing to these goals and look forward to working alongside other sectors and business leaders".

Since FY19, Cipla has added 48 MW of solar energy portfolio through various initiatives such as an on-site roof top or ground mounted solar under RESCO model, third party solar open access power purchase agreement, and group captive solar open access project. The Company recently set up a 30 MW solar group captive project spread across 11 acres in Tuljapur, Maharashtra, making it one of the largest solar open access projects in the state set up by a corporate. By 2025, Cipla plans to achieve carbon and water neutrality, zero-waste to landfill, anti- microbial resistance stewardship and green chemistry.